Navigation Links
Biomoda, Inc. (BMOD) SqueezeTrigger Price is $0.27. Approximately 1 Million Shares Shorted Since November 2006 According to Buyins.net Research Report
Date:11/3/2008

ALBUQUERQUE, N.M., Nov. 3 /PRNewswire-FirstCall/ -- Biomoda, Inc. (OTC Bulletin Board: BMOD) (http://www.biomoda.com), a development stage medical diagnostics company, announced today that BUYINS.NET, http://www.buyins.net, is initiating coverage of Biomoda after releasing the latest short sale data to October 2008. From November 2006 to October 2008 approximately 13.6 million total aggregate shares of BMOD have traded for a total dollar value of nearly $3.6 million. The total aggregate number of shares shorted in this time period is approximately 1 million shares. The BMOD SqueezeTrigger price of $0.27 is the volume weighted average short price of all short selling in BMOD. The first of several short squeezes is expected to begin when shares of BMOD close above $0.05, where approximately 16,000 shares have been shorted. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.buyins.net.

Month Total Vol. Short Vol. Avg. Price Short $ Value

November '06 1,350 104 $3.50 $364

December 12,500 963 $2.90 $2,791

January '07 476,123 36,661 $1.77 $64,982

February 306,044 23,565 $0.96 $22,682

March 381,010 29,338 $0.75 $22,077

April 442,725 34,090 $0.65 $21,988

May 1,092,498 84,122 $0.49 $41,430

June 1,750,488 134,788 $0.23 $31,001

July 2,658,260 204,686 $0.12 $23,539

August 1,565,381 120,534 $0.06 $7,774

September 423,743 32,628
'/>"/>

SOURCE Biomoda, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Biomoda, Inc. Retains MicroCap Management, LLC as its Lead Corporate Communications and Broker Relations Firm.
2. AEterna Zentaris Receives Notification from Nasdaq Relating to Minimum Bid Price
3. Keryx Biopharmaceuticals Notified that Nasdaq Has Extended Minimum Bid Price Rule Compliance Period
4. Spherix Receives Nasdaq Letter Extending Minimum Bid Price Compliance Period
5. Peregrine Pharmaceuticals Receives Additional Time to Regain Compliance With NASDAQs Minimum Bid Price Rule
6. NASDAQs Temporary Suspension of Minimum Bid Closing Price Rules Extends Insmeds Compliance Date to March 20, 2009
7. Insmed Announces That NASDAQ Temporarily Suspends Minimum Bid Closing Price Rule
8. Vista Partners Updates Coverage on Arana Therapeutics (ASX: AAH; AIM: AAHx), Raises Target Price to AU$1.65
9. Vista Partners Updates Coverage; Maintains $3.20 Target Price
10. Neptune Technologies decided not to re-price options
11. Emerging Growth Equities, Ltd. Initiates Coverage of CombiMatrix Corporation with a BUY Rating and an $18.00 Price Target
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... (PRWEB) April 16, 2015 Proove ... Buzz of BIO Contest for the 2015 ... (BIO), the 2015 BIO International Convention will take place ... Pennsylvania. During the Buzz of BIO contest, industry leaders ... see present at the conference. The community voting period ...
(Date:4/16/2015)... (PRWEB) April 16, 2015 ... at Charlotte (UNC Charlotte) spin-out company, announced today ... Cooper, Ph.D., M.D., as Chief Operating Officer (COO). ... of experience in developing clinical diagnostic and biotechnology ... infectious disease. , Cooper’s extensive career transcends the ...
(Date:4/16/2015)... ROCKVILLE, Md. , April 16, 2015 /PRNewswire/ ... "RegeneRx") today announced its U.S. joint venture with ... conduct a phase 3 clinical trial for the ... dose-response, confirmatory trial for dry eye syndrome (DES) ... ReGenTree,s preservative-free eye drops, RGN-259/GBT201, this year.  Each ...
(Date:4/16/2015)... , April 16, 2015  AnaptysBio, Inc., ... of therapeutic antibodies, today announced the advancement ... program into IND-enabling studies. The Company,s anti-IL-36R ... treatment for generalized pustular psoriasis (GPP), an ... medical need. ANB019 is wholly owned within AnaptysBio,s ...
Breaking Biology Technology:Proove Bisociences to Participate in the Buzz of BIO at the 2015 BIO International Convention 2Proove Bisociences to Participate in the Buzz of BIO at the 2015 BIO International Convention 3OncoTAb Names Dr. David L. Cooper as COO 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 3RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 5AnaptysBio Advances First-In-Class Anti-IL-36 Receptor Antibody Program To Treat Orphan Inflammatory Disease 2
... Inc. (Nasdaq: TSRX ) announced today that Jeffrey ... will participate in a panel discussion on antibiotic drug development ... to Kill Superbugs: Novel Antibiotics to Hit Drug Resistant Bacteria, ... 5th at the Westin Waterfront Hotel in Boston. ...
... (Nasdaq: OREX ), a biopharmaceutical company focused ... of its upcoming Contrave® (naltrexone sustained release (SR)/bupropion SR) ... of The Obesity Society. This meeting will be held ... October 10:  Embargo Lifts October 10 at 12:30 p.m. ...
... - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI ) announced ... Annual BIO Investor Forum on Wednesday, October 6 at 10:30 ... Live webcasts from this conference will be available ... at http://ir.oncogenex.com . Webcast replays will be available approximately ...
Cached Biology Technology:Orexigen® Therapeutics Announces Upcoming Data Presentations at the 28th Annual Scientific Meeting of The Obesity Society 2OncoGenex Pharmaceuticals to Present at the 9th Annual BIO Investor Forum 2
(Date:3/23/2015)...  In the 2014 fiscal year, irs.gov recorded over ... figure accounts for a fraction of the estimated losses ... exceeds $11 billion globally. The polygraph has traditionally been ... occurred. Investor Mark Saint Juste along with ... partnered to administer the test in a new ...
(Date:3/20/2015)... and Markets ( http://www.researchandmarkets.com/research/rswjb4/hand_geometry ) has announced the ... Report" report to their offering. This report ... The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... Annual estimates and forecasts are provided for the period ...
(Date:3/19/2015)... 19, 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ... the growing mobile commerce market, announces its biometric payment technology, ... that aired this week on Washington DC,s ... In a segment "The Next Great Thing", host Laura ... to pay, and ,a really big breakthrough in mobile payment.,  ...
Breaking Biology News(10 mins):Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 2Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 4NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3
... have wondered why ovarian cancer cells are so attracted ... hope that such an understanding could lead to better ... series of experiments suggest a two-step model of omental ... and lodge within immune cell-containing structures known as milky ...
... 2013 http://www.researchandmarkets.com/research/xmlpcb/siliconbased has ... Sensors - Global Strategic Business Report " report ... This report analyzes the worldwide markets ... Million by the following Types: Swipe Sensors and ...
... team led by William Fenical at Scripps Institution of ... chemical compound from an ocean microbe in a preliminary ... for new treatments for anthrax and other ailments such ... reported in the international edition of the German journal ...
Cached Biology News:Ovarian cancer metastases influenced by factors in target tissues 2Ovarian cancer metastases influenced by factors in target tissues 3Silicon-based Fingerprint Sensors - Global Strategic Business Report 2Silicon-based Fingerprint Sensors - Global Strategic Business Report 3Compound discovered at sea shows potency against anthrax 2
Form: Ready to use Applications: Western Blot, ELISA...
This kit only detects beta-galactosidase activity at pH 6 in cultured cells andtissue sections. Beta-galactosidase activity at pH 6 ispresent only in senescent cells, and is not found inpresenescent...
For the quantitative determination of cyclic AMP (cAMP) concentrations in cell culture supernates, serum, plasma, saliva, urine and cell lysates....
FRACTALKINE [Human] (Recombinant)...
Biology Products: